Researchers reveal new way to potentially fight Ebola

March 6, 2018, University of Guelph

More than 11,000 people died during the Ebola outbreak in West Africa from 2013-16, demonstrating both the deadly nature of the virus and the limitations of the medication used to fight it.

Now, University of Guelph researchers have shown that an innovative antibody delivery method could offer an effective way to prevent and treat Ebola infection.

"Our goal is to make an antibody-based therapy that can protect against all strains of Ebola, and potentially Marburg , as well," says Prof. Sarah Wootton, Department of Pathobiology, who, along with PhD student Laura van Lieshout, found a new way to fight Ebola. "It would be used to stop the spread of the virus in outbreak situations."

Wootton says monoclonal antibody therapies (mAbs) hold promise for the treatment of Ebola virus infections. But mAbs are costly to produce and provide only short-term immunity.

That could change, thanks to a recent discovery by Wootton and van Lieshout. Their findings were published in the Journal of Infectious Diseases.

The approach delivers a monoclonal antibody gene through a viral vector, something that has been done before, most notably with . The process bypasses the need for the host to generate a natural immune response, which can take several weeks to occur, and often too late for Ebola victims.

The U of G researchers found that using adeno-associated virus (AAV) to deliver was remarkably effective at keeping Ebola virus infection at bay in mice. Other researchers have used AAV extensively to treat a variety of genetic disorders. The United States Food and Drug Administration has recently approved an AAV gene therapy to treat a rare retinal disorder.

"If you use an AAV gene therapy vector to deliver the DNA blueprint to a cell, that cell will produce a protective antibody against Ebola virus, which is then secreted into the bloodstream and protects mice from infection," says Wootton.

The approach provided 100-per-cent protection against Ebola infection in mice using two different types of mAb, and 83-per-cent protection with a third. A "cocktail" of two antibodies provided sustained protection against Ebola for up to five months.

Once the antibody gene is delivered, antibodies will be continually produced in the bloodstream, Wootton says. Mice in the laboratory expressed the antibody for more than 300 days.

"We are hoping to use this technology in a post-exposure scenario. Let's say someone has been exposed to Ebola. The idea would be to give them this AAV vector to start producing the antibodies that prevent death."

Her Ebola research was sponsored by the Canadian Institutes of Health Research (CIHR) and was done in collaboration with renowned microbiologists Xiangguo Qiu and Gary Kobinger at Winnipeg's National Microbiology Lab, Public Health Agency of Canada.

"Developing pan-Ebola or pan-filovirus vaccines and therapeutics has been a goal for all the scientists in the field," said Qiu. "Our preliminary data is really encouraging and we will move forward to develop pan-Ebola/pan-filovirus cocktails."

Wootton is now seeking research funding for human clinical trials from the Coalition for Epidemic Preparedness Innovations, formed after the Ebola outbreak in West Africa.

Explore further: Ebola virus infects reproductive organs in monkeys

Related Stories

Ebola virus infects reproductive organs in monkeys

February 8, 2018
Ebola virus can infect the reproductive organs of male and female macaques, according to a study published in The American Journal of Pathology, suggesting that humans could be similarly infected. Prior studies of survivors ...

Researchers inhibit Ebola virus

December 29, 2017
The incurable Ebola virus has long been feared due to its high mortality rate and danger of infection. Now researchers from the University of Copenhagen and Phillips Universität Marburg have succeeded in inhibiting the virus ...

Experimental Ebola antibody protects monkeys

February 25, 2016
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues have discovered that a single monoclonal antibody—a protein that attacks viruses—isolated ...

Experimental immunotherapy zaps two most lethal Ebola virus strains

January 13, 2016
Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potently neutralize the two deadliest strains ...

Scientists discover workings of first promising Marburg virus treatment

January 10, 2018
With a mortality rate of up to 88 percent, Marburg virus can rip through a community in days. In 2005, an outbreak of Marburg virus struck a pediatric ward in the country of Angola. With no treatment available, doctors struggled ...

Super cell to contain deadly Ebola virus discovered in Australia

July 18, 2017
A super cell in the eye has been discovered that can stop the deadly Ebola virus.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.